Page 1

Lor d Darzi

Exclusive interview Adam,Rouilly

Serving medical education worldwide

MEDICA 2011 Preview

Dusseldorf 16-19 November

Guy’s and St Thomas’s

Going International

World Health Care Congress Middle East 2011 Preview

MEH Awards 2011 winners announced and profiled inside

Abu Dhabi 11-13 December

www.middleeasthospital.com


Editor’s intro Welcome to the November issue of MEH. With the MEDICA trade show starting on 16th November this is a vital time for med-tech companies seeking new customers and markets to meet buyers and distributors from across the globe. The show is also an ideal shop window for hospitals looking for the latest piece of cutting-edge equipment. We preview the show and also showcase the winners of this year’s MEH Health and Innovation awards, many of whom will be exhibiting at MEDICA. Adam,Rouilly are one of the winners, and we look at their impressive array of training aids that will be on show at MEDICA. The award presentation will take place next month in Abu Dhabi at the World Health Care Congress Middle East. This issue’s cover feature is an exclusive and in-depth interview with Lord Ara Darzi, in which he share his views on healthcare innovation, the NHS, and much more. Also, Guy’s and St. Thomas’s hospital explain why they are looking to expand their horizons by building on their current consultancy and philanthropic work overseas. Editor: Guy Rowland Publisher: Mike Tanousis Associate Publisher: Chris Silk MEH Publishing Limited Company Number 7059215 151 Church Rd Shoeburyness Essex SS3 9EZ United Kingdom Tel: +44 01702 296776 Mobile: +44 0776 1202468 Skype: mike.tanousis1

November 2011 contents 4.

COVER FEATURE Exclusive interview with Lord Ara Darzi The renowned surgeon and author of the NHS Review talks to MEH about innovation in healthcare, UK medical technology excellence, and the future of the NHS

12.

Adam,Rouilly Serving medical education worldwide We profile the medical training aid specialists, and talk to new Sales and Marketing Manager, Tariq Shahab

16.

Guy’s and St. Thomas’s Hospital Commercial Director at the famous London hospital, Hugh Risebrow, explains why they are going international

22.

MEH Award Winners Announced All the winners of MEH’s 2011 awards for companies and healthcare providers who have made an outstanding contribution to healthcare in the Middle East over the last year officially announced

38.

The Nine Translation Slip-ups to Avoid Levent Yildizgoren of TTC Language Services points out the common pitfalls of business translation

40.

Preview: World Health Care Congress Middle East 10-13 December 2011, Abu Dhabi Final speaker line-ups for the Middle East region’s premier healthcare conference

42.

MEDICA-COMPAMED 2011 Preview 16-19 November, Dusseldorf, Germany Preview of the world’s biggest med-tech trade show including a look at this year’s ABHI UK Pavilion, and the latest advances in implant medicine

Editor: Guy Rowland Tel: +44 01223 241307 Mobile : +44 07909 088369 guyrowland@middleeasthospital.com Features Editor: Emrys Baird Tel +44 07961391055 em@middleeasthospital.com

UAE distributor Dr Prem Jagyasi MD & CEO ExHealth, P. O. Box. 505131 Dubai HealthCare City, UAE Tel:+971 4 437 0170 Prem@Jagyasi.comm www.ExHealth.com

MEH agent for Egypt Dr.Amr Salah Millennium International Group amr.salah@migaegypt.com Tel: +2 0222736354 Mobile: +2 0122227209

Abu Dhabi & Bahrain office Ms. Pam Page Direct Phone: +971 4 329 1099 UAE Mobile: + 971 50 424 0569 USA Mobile: +617 943 0934 pam.page@worldcongress.com

MEH agent for Saudi Arabia Anwar Al-Qahtani Tejaratna Trading Tahlia Street Riyadh Saudi Arabia Tel: +966 508389039 aburakan01@gmail.com tejaratna@gmx.com For more information about the magazine contact the publisher or editor. Or email MEH at: editorial@middleeasthospital.com

November 2011 | 3


Middle East Hospital

Exclusive interview with Lord Ara Darzi On the eve of Medica MEH interviewed the distinguished surgeon and UK Business Ambassador Lord Ara Darzi on his views on healthcare, innovation, and the future of the NHS. Lord Darzi holds the Paul Hamlyn Chair of Surgery at Imperial College London. MEH: How important is innovation in healthcare? Ara Darzi (AD): Innovation is vital to the quality of healthcare we enjoy today. Modern healthcare is the result of the gradual accumulation of new ideas and new ways of working, and it is absolutely fundamental that we continue to innovate if we want standards to improve further. The application of science and technology has transformed healthcare beyond recognition in the last hundred years or so. And innovations emanating from the UK have had a major impact, benefiting the health and well being of people all over the world. But it’s important to remember that innovation doesn’t just mean technology – it comes in many forms, and as well as improving the quality of care, it helps ensure it’s cost-effective too. So innovation is especially important in an age when the ever increasing demand is putting unprecedented pressure on health budgets.

masses which is free at the point of need, and still costs less per person than in comparable economies – including the US, France and Germany. And that is a result of some really important innovations in the way healthcare is planned, delivered and regulated.

One of the things I’m most proud of about the NHS is that it brings high quality healthcare to the

A great example from the UK is how industry, academia and the National Health Service

collaborate in an integrated network to develop and deliver pioneering products and services; something that’s unique to the UK. MEH: How is innovation encouraged in UK and what are the barriers? AD: Innovation thrives in a trusted and supportive financial and regulatory environment where innovators are also supported by November 2011 | 4


Middle East Hospital

200% in April 2011, and further to 225% in April 2012, subject to state aid approval. 2. Patent Box - the Government is currently consulting on a preferential regime for profits arising from patents (a Patent Box). The Patent Box will provide a reduced 10% rate of corporation tax for profits from patents held in the UK. 3. The National Institute for Health Research leads a health research system in which the NHS supports outstanding clinicians, working in world class facilities, conducting leading edge research focused on the needs of patients and the public. The NIHR will spend £992m in 2010/11 and this is set to increase each year up to 2014.

highly effective and enforced IP laws – and that describes the UK well. Take Cell Therapy as an example. The UK is a leader in the science of stem cells and regenerative medicine. That is combined with our supportive regulatory environment, access to the NHS as a potential lead market, our mature capital markets and established pharmaceutical, biotechnology, medical device

and blood products industry sectors. It’s really no surprise that the UK has the strongest life science economy in Europe. These natural advantages are supported by a system of financial incentives to promote innovation, which include: 1. Raising the SME rate of the R&D tax credit from 175% to

Furthermore, the Technology Strategy Board (TSB), the UK’s national innovation agency, is making fast progress in creating a network of world-leading technology and innovation centres to transform the UK’s capability for innovation in specific technology areas and help drive future economic growth. MEH: How does UK compare with other countries in fostering innovation and breaking new ground? AD: The UK’s track record in fostering innovation is world class. Britain has an enviable tradition of innovation – as evidenced by 85 Nobel Prizes in science and technology alone. This is largely a November 2011 | 5


Middle East Hospital

Exclusive interview with Lord Ara Darzi

The UK is the number one gateway to Europe and one of the top three countries for inward investment in the world. It benefits from local and global connectivity which creates networks to accelerate business development and commercial success.

universities produce a large number of science and engineering graduates, both at first degree and doctoral levels, and host a very large number of international doctoral students. International collaboration in research and higher education is embedded in UK universities. The UK is the second leading producer, after the USA, of publications in top journals, the majority of which are co-authored with international researchers.

The UK has a world class science and research base, second only to the USA in terms of output. The UK reputation in this area is a crucial asset for the future. UK

But if you stand still, you go backwards. So, together with the Government, industry is working hard with regulators and the NHS in order to understand the issues

result of the quality of our universities and our research base, but it’s also a result of a business environment that encourages innovation to flourish.

impacting on our competitiveness and to make sure that the right policies are in place to ensure we continue to be at the cutting edge. For example, the Government has recently undertaken a Growth Review which prioritises the healthcare sector and is taking steps to promote collaboration and innovation. And NHS Chief Executive Sir David Nicholson has instigated a review into how the spread of innovations can be accelerated across the NHS. MEH: How can UK companies with innovative new products break into the Middle East markets? November 2011 | 6


Middle East Hospital

Exclusive interview with Lord Ara Darzi AD: Firstly, I would recommend that they contact UK Trade & Investment, the Government department which helps innovative companies bring their products to overseas markets. In the world of business, face-toface contact is still vital and trade shows like Arab Health are a chance for UK firms to showcase their excellence and innovation against the rest of the world. Around 200 UK companies exhibited at the event this year – which I think reflects the scale of the opportunity and shows the appetite of UK companies to engage in the Middle East. I’d also emphasise how important it is to find the right local partners to work with – and the best way of doing that is by getting out here in person. MEH: How has UK innovation benefited the Middle East, and what could be done to increase knowledge/technology transfer? AD: The UK has a well established heritage of working in partnership with the Middle East. For example, The Qatari Foundation established a centre for robotic surgery with Imperial College London at the Qatar Science & Technology Park. The Hamlyn Centre for Robotic Surgery is a centre of excellence for the integration of robotics into medicine and patient care. Established by Imperial College London (ICL) in 2008, the centre focuses on the development of

November 2011 | 8


Middle East Hospital

advanced robotic technologies to transform keyhole surgery, empower robots with human intelligence, and create revolutionary ‘microbots’ for cancer surgery and treatment. Imperial College London (ICL) brought years of experience in diabetes treatment to Abu Dhabi, where an estimated 25 per cent of the population suffers from diabetes. The aim is to improve health outcomes and provide continuing education for health professionals and the general public. With comprehensive inhouse diagnostic and treatment facilities, including digital retinal photography, lasers therapy and stress testing, ICL now provides the highest level of specialised patient care in the region Just a few weeks ago I led a group of the UK’s leading clinicians on a visit to the Kingdom of Saudi Arabia with the aim of forging new partnerships with like minded Saudi Arabian institutions, and I was not surprised that we uncovered a great many areas in which collaboration could bring mutual benefits. This will be followed up by a more commercially focussed mission in December. MEH: Will the new NHS Bill encourage or stifle innovation, and how? AD: The new NHS Bill promises to encourage the uptake of innovation in the NHS by putting commissioning in the hands of

Examples of UK healthcare and life sciences innovations The UK is home to many of the world’s most innovative medical technology companies. They have an enviable record of creating products which improve health and well being and improve the delivery of healthcare. Some outstanding examples include: – Touch Bionics developed the world’s first commercially available multi-articulating bionic hand – Deltex Medical developed CardioQ-ODM, the only technology to monitor the rate of blood flow around the body accurately and in the central circulation during surgery.. This allows clinicians to use fluids and drugs to optimise oxygen supply around the body and thus protect key organs and improve the recovery post surgery. – Aircraft Medical’s portable video laryngoscope for difficult intubations is a world first. Fundamental research conducted in the UK has revolutionised many areas of healthcare such as: –

In-vitro fertilisation

– The discovery of monoclonal antibodies which has led to the development of targeted treatment for auto-immune diseases like Rheumatoid Arthritis and several cancers – The UK has pioneered advances in surgery, such as minimal invasive surgery and robotic surgery which have improved outcomes for patients as well as increased the efficiency of hospital. The UK is a leader in the development of eHealth, telehealth and mobile health for remote patient monitoring, The application of information technology to healthcare is creating new approaches to management and improving the outcome and experience for patients: – The UK hosts the European Centre for Connected Health in Belfast, Northern Ireland. – The NHS Whole System Demonstrator is the world’s largest randomised trial of telehealth and telemedicine

practitioners who have a real grasp of patients’ needs. It will also improve levels of transparency in the way services are commissioned, which will empower patient choice.

MEH: How do you envisage the future of the NHS and healthcare provision in the UK? AD: First and foremost, that patients should no longer be

November 2011 | 9


Middle East Hospital

Exclusive interview with Lord Darzi passive recipients of care, but active participants in it. That they should have real choice as to how, where and by whom they are treated and that they should be an equal partner in decisions taken about their care. Second, that clinicians should lead the design of services. The top-down approach just doesn’t work any more. It smothers innovation, undermines professional judgement and leads to worse, not better care for patients. And third, we need to focus all of our resources, all of our talent, all of our energy on the things that really matter most to patients - we need to focus on outcomes because healthcare should be about quality as well as quantity. And this will have the added benefit of making our system more cost-effective. MEH: What challenges do you see for improving healthcare services in the Gulf? AD: In common with many other countries around the world, both the UK and the Gulf States have a growing burden of noncommunicable diseases such as heart disease and diabetes. This, combined with life style issues which affect health, and the requirements of an aging population, creates an increasing demand for health services. As a result there is a pressing need for Governments to do more around public health awareness and education on how to maintain a healthy lifestyle and identify potential health risks.

Professor the Lord Darzi of Denham KBE Already a highly respected surgeon in his field, Lord Darzi became an instantly recognisable figure throughout the entire healthcare community, and beyond, when he was selected to help determine the future of the NHS. Brought into Gordon Brown’s government as a health minister in the capacity of a non-political expert, Lord Darzi was tasked with conducting a year-long review on the future of the NHS, which was published in June 2008. Currently Professor Darzi holds the Chair of Surgery Imperial College London where he is head of the Division of Surgery, Oncology, Reproductive Biology and Anaesthetics. He is an Honorary Consultant Surgeon at St. Mary's Hospital NHS Trust. He holds the Paul Hamlyn Chair of Surgery at the Royal Marsden Hospital. He held the office of the Tutor in Minimal Access Surgery at the Royal College of Surgeons in England where he set the national guidelines in education and training in Minimal Access Surgery. He was also a Council member of the Association of Coloproctologist of Great Britain and Ireland, The Association of Endoscopic Surgeons of Great Britain and Ireland, and the Society of Minimal Invasive Therapy. Professor Darzi's main clinical and academic interest is in minimal invasive therapy, including imaging and biological research together with investigating methods to measure core competencies of surgery objectively. He has published widely in the field of minimally invasive therapy. Areas where the UK could help the Middle East include in the provision of specialist healthcare facilities to help deliver the vision of world-class healthcare provision, the development of ehealth systems and the use of advanced technologies in healthcare systems. There has been greater cooperation between UK and the Middle East establishments for clinical training at undergraduate and postgraduate level and there are so many more areas where greater partnership between our countries will have long-term benefits and help deliver healthcare excellence.

The UK recently established NHS Global, an organisation that can draw on expertise from the NHS to develop collaborative programmes with overseas partners. That means both between individual institutions, for example in establishing training programmes for nurses and doctors, and at the whole-system level, for example in regulation, financing, or developing a system of primary care. It’s a really exciting development, and it should make a major difference to how the UK’s world-class expertise in the UK is shared with the world. November 2011 | 10


Middle East Hospital

Adam,Rouilly: Serving Medical Education Worldwide

Adam,Rouilly supplies a comprehensive range of medical training aids from Anatomical Models and skeletons to Clinical Skills Simulators and Anatomical Charts. Adam,Rouilly celebrated its 90th Anniversary in 2008 having first supplied natural bone material and anatomical models to Hospitals and medical schools in London in 1918. The business rapidly expanded to all areas of Great Britain and

within ten years a flourishing export business was established. The first patient simulator (the Bedford Hospital Nurse Demonstration Doll) was manufactured in1930 and continues to be sold to this day. The name Adam,Rouilly is recognised throughout the world by healthcare professionals for the manufacture and supply of high quality medical training aids. From its base in Sittingbourne,

Kent, Adam,Rouilly has been exporting to customers throughout the world for nearly 80 years and has long established relationships with many world famous medical training institutions, nursing colleges hospitals and universities. Graham Fowler has been with Adam,Rouilly since 1969. In 1972 he moved from Administration to Sales and since then has been the motivating force behind the November 2011 | 12


Middle East Hospital

Visit Adam,Rouilly in the UK Pavilion at Medica Hall 16, Stand G20-2

Sales and Marketing of the Adam,Rouilly brand and range of products which globally are so well known. Having represented Adam,Rouilly for over 40 years Graham Fowler is well known in the healthcare education market and over the past twenty years he has extended the Adam,Rouilly presence into the Middle East. Tariq Shahab recently joined Adam,Rouilly and will take over as Sales and Marketing Manager

following Graham's retirement in Spring 2012. Tariq formerly worked in the pharmaceutical industry for several years and with recent experience marketing and promoting products in the Middle East he told Middle East Hospital: “I am looking forward to furthering Adam,Rouilly’s presence in the Middle East as the company has such an established reputation for offering quality products and excellent customer service.”

Adam,Rouilly has attended MEDICA for the last 25 years and is now a regular exhibitor on the ABHI UK Pavilion finding it an excellent platform for meeting distributors from around the world, including those from the Middle East with whom we have established good relationships, since first attending Arab Health in 2004. Adam,Rouilly sells to customers in more than fifty countries November 2011 | 13


Middle East Hospital

Adam,Rouilly: Serving Medical Education Worldwide Visit Adam,Rouilly in the UK Pavilion at Medica Hall 16, Stand G20-2

throughout the World. Their large range of products has been carefully designed, developed and selected in direct response to customers’ requirements and preferences. Speaking to Middle East Hospital on the subject of export sales in the Middle East Tariq Shahab said: “Adam,Rouilly has a very reliable distributor network in the Middle East which is a very important part of our export market. There is an increased demand for skills training and our broad product base enables us to help hospitals who are implementing or

expanding these Clinical Skills Training facilities. There is an additional requirement for anatomical models in the medical schools at the Universities and we offer what we believe to be the highest quality range on the market.” “Within the Middle East we sell into many hospitals, almost exclusively through our distributors within the various countries. We have seen a considerable increase in both enquiries and business from Saudi Arabia, Yemen, Jordan, UAE and Syria although we

supply most countries in the area at some time in the year.” Mr Shahab continued, “The success of Adam,Rouilly’s Export Sales is due to the hard work of our dedicated sales team. In 2010 we achieved 50% of our total sales in export markets with significant sales in the Middle East. The expansion of Clinical Skills Training in Hospitals in the Middle East is a major factor in these achievements.” Adam,Rouilly continually improves its existing products in response to customers' needs and the November 2011 | 14


Middle East Hospital

evolvement and changes taking place in medical education. Following extensive market research, the AR251 Venepuncture and Infusion Arm has been improved utilising improved manufacturing techniques and materials to offer an even more like life training scenario. Cast from life the moulding of the Infusion Arm Trainer incorporates new features with an improved vein system and silicone skin resulting in an extremely realistic finish which shows a well developed male left arm in fine details. Tariq reports “this improved arm has been well received by customers especially as we offer both white and black skin tones which successfully broaden our customer base. Customers also particularly like the closed blood system which is clean and easy to use and reduced the risk of leakage�. Their award winning Hungry Manikin is another product which is sold worldwide. This model was designed by two nutrition nurses at Birmingham Children’s Hospital to demonstrate to parents/carers the technique for insertion of Nasogastric and Gastrostomy tubes. Recent improvements facilitate training in a wider range of procedures increasing the popularity of this valuable teaching which Tariq reports has been reflected in an increase in sales particularly in the Middle East. Now with the ability to accept fluids in the

stomach the Hungry Manikin can be used to teach the procedures necessary for feeding and medicating nasogastrically including aspiration, pH measurement of stomach contents, enteral feeding via nasal or gastric tubes and the introduction of liquid based medicines. These improvements have increased the market appeal of the Hungry Manikin and as a result received a Middle East

Hospital award for outstanding contribution to health Care in the Middle East - education category. The other most popular products with Adam,Rouily customers are the X-Ray Positioning Doll, Diabetic Retinopathy Trainer, Rectal Examination Model, the Bedford range of Hospital Training Dolls, Pain Relief Manikin and Rhinoplasty Model. www.adam-rouilly.co.uk

November 2011 | 15


Middle East Hospital

Special feature: Guy’s and St. Thomas’s Hospital

Why Guy’s & St Thomas’s is going International, by Hugh Risebrow, Commercial Director Guy’s and St Thomas’ NHS Foundation Trust compromises two of London’s longest established and best known teaching Hospitals – St Thomas’ Hospital (founded in the 12th century) and Guy’s Hospital (founded in the 18th). The Trust employs over 12,500 staff on the two sites and more recently in the local community, and offers both comprehensive community and secondary services to the local

population as well as a wide range of specialised tertiary services to a much broader national and international population. Since 2008, the Trust has collaborated closely with the Medical Schools of King’s College London, King’s College Hospital, South London and Maudsley – a major NHS mental health trust – to create King’s Health Partners, one of five Academic Health Sciences Centres in the UK. King’s Health Partners has an ambitious vision to improve

outcomes for patients through better integrating teaching, research and clinical practice. Along with some other London teaching hospitals, Guy’s and St Thomas’ has historically undertaken a limited amount of international work. Some of this has been philanthropic programmes aimed at capacity building in sub Saharan Africa the trust has specific links with two hospitals in Zambia and one in Tanzania. Other international work has been on a commercial basis, and this has included November 2011 | 16


Middle East Hospital

managing healthcare for British Military Forces and The Foreign and Commonwealth Office overseas, as well as consultancy work advising hospitals and health ministries in a range of countries including Qatar, UAE and Egypt. Overall, NHS trusts have historically played a limited role in international healthcare projects relative particularly to US, but also to Canadian and Australian, teaching hospitals. Becoming part of an Academic Health Sciences Centre has provided renewed impetus and Guy’s & St Thomas’ to developing international opportunities. Within my commercial team at the Trust we have an associate director dedicated to international development supported by a small team. Aside from the financial benefits of working internationally – and these are reinvested into NHS care – the Trust is pursuing international opportunities for a range of reasons, which fall into two broad areas: Firstly, we believe that we have something unique to offer. Secondly we believe that we have much to learn and gain by working overseas. So, what can Guy’s and St Thomas’ offer? Clearly what we offer internationally is tailored to the needs of each client and each situation. We are currently at various stages of projects ranging from: design, build and operate new hospital facilities (as clinical partner in a consortium); contracts

to manage existing facilities (again in partnership with others who have complementary skills); contracts to deliver specific clinical services in an overseas country by flying our clinicians out several times a year; contracts to train clinicians based in other countries, combining training in England with training in their own country; and, a range of consultancy type projects. Perhaps the question should be what can Guy’s and St Thomas’ offer which is unique? Like a number of leading teaching hospitals around the world, we have a large number of nationally and internationally regarded medical staff, working in teams with the high calibre of clinicians and managers that institutions such as ours attract. Our Medical staff is very diverse, and many are very willing to

undertake regular international visits to broaden their experience. The NHS is very unusual in providing (mainly) free care to patients, and in spite of recent funding increases, it has managed to continue to do this at a significantly lower percentage of GDP expenditure than ‘competitor’ countries. This means that clinical teams have had decades of experience of looking at how to improve clinical outcomes, whilst containing and reducing costs per episode. The NHS is almost uniquely placed to deliver high quality care as cost effectively as they do. Whilst all hospitals would say that delivering high quality care is their primary concern, Guy’s and St Thomas’ has an outstanding track record of achieving the highest ratings from

November 2011 | 17


Middle East Hospital

Special feature: Guy’s and St. Thomas’s Hospital NHS inspection bodies, and has recognised expertise in clinical governance and patient safety. The medical schools were part of the hospitals before they became part of King’s College London, and school and hospitals have worked closely for decades. The formation of the Academic Health Sciences Centre has led to new ways of working where teaching, research and clinical practice in a clinical area are combined into a clinical academic group or CAG – for example, academic cardiologists are now working as part of a team with clinicians much more than as part of a university. This gives Guy’s and St Thomas’ the opportunity to provide solutions which encompass the full spectrum of delivering clinical services, educating and training local clinicians, and extending research to cover international activities. Guy’s and St Thomas’ has also begun to look at its own ‘value chain’. Like most organisations, we do some things exceptionally well and others less so. A new approach is being taken to our core business, and a good example of this is pathology, where historically we had outstanding scientists, but lacked excellence in other important areas of delivery high quality pathology such as IT and logistics. A joint venture was formed with a commercial partner in 2008, which combines the Trust’s scientific excellence with

the partner’s IT, logistics and transformation skills. The relevance of this to our international activities is that the Trust knows that it doesn’t make sense to do it all single handed – the Trust has a range of strategic alliances, for example with health planners, architects, healthcare IT companies and other specialist service providers, and has demonstrated that it can bring a combined ‘best of breed’ solution to any requirement. Other than for financial reasons, why is Guy’s and St Thomas’ keen to work internationally? the Trust believes that it will increasingly be a contributory factor to recruitment, retention and development of the calibre of clinical and management talent that is needed to sustain a world class Academic Health Sciences Centre. Talent has choices, and providing development

opportunities can be a factor. As an example, we already recruit outstanding management trainees from the NHS management training scheme. If we were able to offer more of them a 2-3 year management role overseas, this would offer them new career development opportunities and improve our retention. Whilst St Thomas hospital has outstanding views of the houses of parliament, and Guy’s sits in the shadow of ‘The Shard’, Europe’s tallest building, the populations which the Trust serves are economically very deprived, ethnically very diverse – over 140 different first languages, and burdened by high levels of chronic disease, HIV, and other conditions. The Trust needs to continue to develop its world class expertise in researching and treating these conditions, and November 2011 | 18


Middle East Hospital

Special feature: Guy’s and St. Thomas’s Hospital believes that international opportunities will contribute to that. Clinicians have the opportunity to see and learn about different disease presentations and different conditions which contributes to CPD. The Trust is conscious that its primary duty as an NHS body is to treat NHS patients, but as explained above, the international strategy will clearly do this. Whilst the Trust is willing to invest its expertise internationally, it is unable to invest significant capital, which has to be prioritised for treating NHS patients. Overall, the Trust is very excited about the increasing internationalisation of healthcare and very much wants to be a part of this trend. About the author Hugh joined Guy’s and St Thomas’s NHS FT as Commercial Director in 2009, where he is responsible for managing and developing a portfolio of revenue diversification activities and partnerships. Prior to this, he was CEO of Interhealth Canada in Europe which operated one of the most successful wave 1 ISTC contracts, among other contracts to deliver acute healthcare services. His previous experience includes roles as Business Development Director at United Health Europe, CEO of BUPA Dental, CEO of Aid-Call plc, and lead for financial recovery within the NHS Modernisation Agency. His early career was in strategic consultancy with Bain & Co and Kalchas. He has an engineering degree from Cambridge University. He lives in the New Forest with his wife Sarah, four children and a variety of animals.

November 2011 | 20


Middle East Hospital

MEH Health and Innovation Awards Since the opening of nominations for our 2011 Healthcare and Innovation Awards for exporters of medical equipment to the Middle East, and healthcare providers, there has been a high number of applications from companies and healthcare providers from all areas of the industry. The awards are now in their second year. Last year’s awards were presented at Arab Health 2010 by Lord Darzi, the distinguished surgeon and UK business ambassador. This year the winners will be presented with their awards at The World Health Care Congress

being held in Abu Dhabi from 11-13 December 2011. The awards’ categories cover manufacturers and providers of hospital equipment, nursing equipment, respiratory devices, preventative solutions, surgical equipment, and more. New products for export to the Middle East are being recognised, as well as established products that have already made a significant contribution to healthcare in the region. There is also a section for the best exporters from the most prolific exporting regions and countries, and awards for hospitals, companies or individuals that

have made outstanding contributions to healthcare in the Middle East region. These awards are intended to recognise the contribution of companies from across the globe to healthcare services in the Middle East, as well as highlighting the best hospitals within the Arab world. After careful consideration of all applications by our expert panel MEH can now announce the winners of the 2011 MEH Health and Innovation Awards. We profile the foreign companies that have won awards in this issue, and will profile the Middle East-based hospitals in the December issue.

Winner of the outstanding contribution to healthcare in the Middle East: preventative technology Bedfont Scientific for the NOxBOX O2 NOxBOX®O2 is the next generation in Nitric Oxide (NO) monitoring. It is a standalone side stream system which allows accurate, real-time monitoring of NO, NO2 and oxygen (O2). Compact and easy to operate, the unit can be set up and used by non-technical staff. INO Therapy is beneficial as it prolongs the time available for treating the disease or trauma underlying symptoms such as hypoxia and hypertension. NO has a fundamental advantage over infused vaso-dilators in that it acts only in the ventilated areas of the lung. NO is highly chemically reactive, it combines with Oxygen (O2) to form Nitrogen Dioxide (NO2), which in turn can combine with water to

Visit Bedfont at Medica Hall 11, Stand B29 become damaging nitrous and nitric acid. Delivery of NO should provide monitoring of NO2 to ensure patient safety. Patients undergoing INO therapy will become dependent on their treatment as after a few days it will prevent the body’s natural production of NO. Patients must

be weaned from the therapy gradually. Sudden withdrawal due to, for example, exhaustion of a gas cylinder or supply disconnection can be extremely detrimental, so delivery systems must address this issue. www.bedfont.com November 2011 | 22


Middle East Hospital

MEH Health and Innovation Awards The Winners Award for most innovative product for export Surgical instrument category Swann Morton for the Cygnetic scalpel Diagnostic technology category Medibord for the Medibord radiotherapy and MRI compatible panel Educational product category Mediskills for the Advanced Scope Trainer ENT product category Mirage Health Group for the Propulse Proscoop ear wax removal scoop Preventative technology category Paxman Coolers for the Paxman Scalp Cooling System Hospital equipment category Sidhil for the Innov8 Hospital Bed Nursing equipment category Malem Medical for the Universal Wireless Alarm Award for outstanding contribution to healthcare in the Middle East Surgical instrument category Bolton Surgical for their range of surgical instruments Educational category Adam, Rouilly for the Hungry Manikin Preventative technology category Bedfont Scientific for the NOxBOX O2 Hospital equipment category DDC Dolphin for the Pulpmatic+ Macerator Nursing equipment category Tenscare for the iTouch Plus TENS unit National and regional awards European Middle East exporter of the year: Durbin American Middle East exporter of the year: Welch Allyn British Middle East exporter of the year: LEEC German Middle East exporter of the year: TRUMPF MEH excellence in healthcare awards MEH award for excellence in women’s healthcare: Abdul Rahman Al Mishari Hospital MEH award for excellence in respiratory care: Michael Oko, Snore Centre founder MEH award for excellence in healthcare recruitment: Pulse International MEH award for excellence in healthcare research: Weill Cornell Medical College- Qatar MEH award for excellence in health translation: TTC Language Services MEH award for excellence in cancer care: King Faisal Specialist Hospital MEH award for excellence in diabetes care: Imperial College London Diabetes Centre Abu Dhabi MEH award for excellence in rehabilitative care: IMC Jeddah

November 2011 | 23


Middle East Hospital

MEH Health and Innovation Awards Winner of the most innovative product for export in the diagnostic technology category Medibord for the Medibord radiotherapy and MRI compatible panel With the challenges that today’s world faces, there are increasing demands to supply a service or product that offers exceptional value for money whilst providing an innovative environmentally positive and sustainable solution. The Medibord is the result of these challenges being identified and engineered to fulfil the high demands of the medical sector. The lightweight, reinforced thermoplastic panel is ideally suited for a number of applications in the medical sector but provides a unique advantage due to its MRI and CT compatibility. www.medibord.com

Winner of the most innovative product for export in the educational product category Mediskills for the Advanced Scope Trainer The Advanced Scope Trainer utilises a clear acrylic casing more suited to the actual demonstration of the properties of a flexible ureteroscope to potential customers. It incorporates features such as distensible bladder, a realistic ureteric orifice and a ureter, which follows the same anatomical course as the adult male, thus providing a realistic alternative to training in patients. In addition the AST has one enlarged kidney and a distorted ureter allowing the trainee ureteroscopist to develop a feel for the difficulties that may be encountered during real-life procedures in patients. www.mediskills.com

November 2011 | 24


Middle East Hospital

MEH Health and Innovation Awards Winner of the most innovative product for export in the nursing equipment category Malem Medical for the Universal Wireless Alarm

Visit Malem in the UK Pavilion at Medica Hall 16, Stand G20-1 For 30 years Malem Medical have been manufacturing the world’s best and largest range of Enuresis Alarms and Vibrating Watches for the treatment and permanent cure of Nocturnal as well as Diurnal Enuresis.

sensor (such as Enuresis body worn Sensor; Bed-Mat Enuresis Sensor; Pressure-Mat; and Pressure Release Mat) to help detect patient movement and prevent dangerous falling or unauthorised wondering.

Malem Enuresis Alarms (bedwetting alarms) are designed to maximize success in the treatment and cure of bedwetting and provide a safe, efficient, economical and permanent cure for bedwetting in contrast to the short term relief offered by expensive and potentially dangerous drugs.

One small battery operated receiver that can be carried by the carer will communicate with up to seven Transmitters. This Universal wireless product is ideal for nursing/care homes, or for use at home.

With the latest Universal Wireless alarm you can use up to seven transmitters, each one of them can be attached to a different

The Malem Bedwetting Alarm consists of a safe electronic device contained in a small, ultra lightweight plastic box which is comfortably and discreetly worn on the nightwear top close to the collar bone. The alarm is

connected to a sensor which detects urination. When urination commences and the sensor is moistened, the alarm is triggered and a stimulus is activated. This can be in the form of a loud sound, vibration or light. The Easy-Clip, Standard or Bed-Mat sensors can all be linked to any of the alarms. Repetitive awakening by the Alarm as soon as urination commences will gradually train the brain to exert automatic control over the bladder. Eventually, the bedwetter will either wake up before urination or be cured resulting in them sleeping throughout the night without needing to empty the bladder. www.malem.co.uk November 2011 | 25


Middle East Hospital

MEH Health and Innovation Awards Winner of the most innovative product for export in the preventative technology category Paxman Coolers for the Paxman Scalp Cooling System Hair loss is a well documented side effect of many chemotherapy regimes. It is often devastating and the fear of hair loss has even been known to cause patients to refuse treatment. The revolutionary Paxman hair loss prevention system is responsible for helping thousands of people worldwide keep their hair and their dignity. The Paxman Scalp Cooler is unique - using a lightweight cap made out of silicone which is comfortable and provides a snug fit to the patient’s head. The caps are linked to a compact refrigeration unit which circulates coolant at -6°C through coolant lines and into the cooling caps. Temperature sensors ensure the cap maintains the scalp at a constant temperature throughout the treatment. Consideration and care has gone into the design of the system in order to meet the needs of both the patient and nursing staff. Chemotherapy affects the rapidly dividing cells of the hair follicles and at any given time, 90 per cent of hair follicles are in the actively dividing phase. Cooling the scalp during selected chemotherapy regimes has been shown to reduce or prevent otherwise inevitable total hair loss by restricting the blood flow to the hair follicles, thereby reducing the amount of chemotherapy chemicals reaching them. The Paxman system is simple for nurses to operate as it has easy-to-read digital displays allowing instant visual monitoring. The compact nature of the system makes it easy to manoeuvre and ensures an efficient use of space. As the temperature is maintained by the system, nursing staff do not need to stay with patients during the treatment. www.paxman-coolers.co.uk

November 2011 | 26


Middle East Hospital

MEH Health and Innovation Awards Winner of the outstanding contribution to healthcare in the Middle East in the educational product category Adam,Rouilly for the Hungry Manikin Visit Adam,Rouilly at Medica Hall 16, Stand G20-2

The Hungry Manikin was designed by two nutrition nurses at Birmingham Children’s Hospital to demonstrate to parents/carers the technique for insertion of Nasogastric and Gastrostomy tubes. Recent improvements facilitate training in a wider range of procedures increasing the popularity of this valuable teaching which has been reflected in an increase in sales particularly in the Middle East. Now with the ability to accept fluids in the stomach the Hungry Manikin can be used to teach the procedures necessary for feeding and medicating nasogastrically including aspiration, pH measurement of stomach contents, enteral feeding via nasal or gastric tubes and the introduction of liquid based medicines. www.adam-rouilly.co.uk

Winner of the MEH award for excellence in heathcare recruitment Pulse International Pulse International, recruit doctors, nurses and allied health professionals for jobs in the Middle East, Australia, New Zealand and North America. This division also recruits international candidates for work in the UK. Pulse’s InternationalDirector, Steve Twelftree said, ‘We have worked very hard to understand the region, forge relationships and provide a good service in a challenging environment. Considering the challenges in recruiting to the GCC , we

consider every placement we make as a success story. The challenge in placing candidates is not just about finding a clinical match for our clients but it's also ensuring that they are fully aware about the new culture they are going to so they know what to expect. We have about a 96%

conversion rate in terms of permanent placement (4 in every 100 leave before their probation is completed). Last year we successfully placed over 250 nurses and over 100 doctors and 2012 looks like being an even better year. We were absolutely delighted to be nominated and are even happier to win it! I think for a western recruitment business to be recognised in this way is excellent news and gives us a lot of marketing ability to hopefully attract new candidates and clients in the region.’ www.pulsejobs.com November 2011 | 28


Middle East Hospital

MEH Health and Innovation Awards Winner of the MEH award for excellence in respiratory care Michael Oko, Snore Centre founder Mr Oko has had great success in treating Obstructive Sleep Apnoea (OSA) at his Sleeping Disorders Centre (or Snore Centre) based in the Pilgrim Hospital (Boston, UK), and a newly opened satelite clinic in Johnson Hospital (Spalding, UK). Mr Oko actively campaigns to reduce road deaths caused by sleep apnoea both in the UK and Middle East. He took a stand at the Arab Health exhibition in Dubai this year to raise awareness of the negative impact that OSA is having in the UAE and wider Middle East, and met with healthcare professionals interested in treating this issue in the Arab region. He also attended Saudi Medicare in Riyadh in April to spread the message further around the region, and is speaking at the World Health Care Congress Middle East in Abu Dhabi next month. Mr Oko said, ‘Levels of obesity, hypertension and heart disease are rocketing in the wealthy Middle East, mainly due to the life-style. People are working long hours, eating rich calorie-laden food, driving everywhere and not exercising enough. I believe that the success I have had in Lincolnshire can be replicated in the Middle East by raising awareness of the condition, and forming long-term partnerships with local hospitals, doctors, and government departments.

The Snore Centre at Johnson Hospital

‘With the low level of awareness of sleep apnoea in the Middle East it’s no surprise that road accident rates out in Dubai and the UAE are dreadful. In fact road traffic accidents are the second major cause of deaths in the UAE. There are 3500 fatalities per year from RTAs in Saudi Arabia alone, and OSA could well be a factor in many of them. Mr Oko added, ‘If you treat the condition with The Continuous Positive Airway Pressure (CPAP) you can reduce the rate of car accidents by an estimated 83%.

Indeed, in the Lincolnshire region since the service started there has been a reduction in road fatalities of over 30%. Down from an average of 79 per year in 2006 down to 52 in 2010, a percentage of which will be due to treating the condition effectively.’ The CPAP reatment used to cure the condition is not expensive to administer, and is extremely effective, having been recommended by the UK National Institute for Health and Clinical Excellence (NICE) since 2008. www.snorecentre.com November 2011 | 29


Middle East Hospital

MEH Health and Innovation Awards Winner of the British Middle East exporter of the year award LEEC LEEC Limited is an independent private company which offers the personal service and interest that is so highly valued by all our customers together with the efficiency you expect from a technologically progressive company. With nearly 60 years of experience in the design and manufacture of laboratory incubators and a wide range of other laboratory and mortuary equipment, we remain the clear leader in the field of automatic CO2 cell culture incubators. Paul Venners, Managing Director and owner told MEH, “We employ the latest manufacturing methods, and maintain an excellent record of technical superiority. This consistent policy ensures unrivalled reliability in all products whilst keeping prices competitive. By continuous review and updating of our products, we are able to take advantage of advanced control systems to further enhance equipment performance. Strict attention to customer service by qualified staff in all departments ensures the highest standard of after sales support.” Mr Venners added, “It is our policy to pursue Customer satisfaction by supplying Laboratory and Mortuary products that are Quality assured and delivered on time. In order to achieve this we must remain competitive now and in the future, through continuous quality

improvement from our employees to all aspects of our processes, in accordance with our Quality systems.” LEEC has recently secured export orders for its innovative, state-of-the-art CO2 incubators with the support of the Healthcare and Bioscience iNet. Crucial tests to prove that the incubators can be successfully sterilised prior to use have been carried out with the help of subsidised innovation support from the Healthcare and Bioscience iNet.

turnover company have grown from 15% to 30% in 2010 and the company is aiming for 70% of sales from exports in the next three years. www.leec.co.uk

The test findings to prove efficacy at 200°C have helped generate over 40 orders for the high-spec units. LEEC received a further iNet grant in January to test at 160°C for the Far East market. Export sales for the £6.7 million November 2011 | 32


Middle East Hospital

MEH Health and Innovation Awards Winner of the most innovative product for export in the surgical instruments category Swann Morton for the Cygnetic Scalpel Cygnetic provides the surgeon with additional strength and stability through a patented combination. The blade is manufactured from a thicker specification of stainless steel which is gripped firmly on both sides once secured within the special handle. The Cygnetic handle’s lever operated system allows for safe and easy blade attachment and removal. When the blade needs changing or the procedure is completed, the theatre nurse can simply drop the blade into a sharps container or counter box, with no handling of contaminated sharps. Once the procedure has

Visit Swann Morton at Medica Hall 13, Stand F65

ended the handle can be disassembled by the decontamination and reprocessing centre ready for cleaning. Initially the range will include four stainless steel blade

shapes, the CYG 10, CYG 11, CYG 15 and CYG 20, available in boxes of 50. www.swann-morton.com

Winner of the MEH award for excellence in healthcare translation TTC Language Services TTC provides pharmaceutical translations by specialised translators who have experience working with the pharmaceutical industry. Currently, TTC provides translation services for suppliers of turnkey pharmaceutical plants; machinery and equipment for the treatment of pharmaceutical raw materials; analytical instruments and lab reagents; testing instruments; active pharmaceutical ingredients; tableting and capsulation unit. Director of TTC, Levent Yildizgoren, told MEH, “I cofounded TTC together with Banu Yildizgoren. We were passionate about languages and

communications and wanted to do what we like most: communications. At TTC we are helping our clients to be at the leading edge of revolutionary changes in language communications. Since the industry is so complex with many different types of drugs (brand name and generic medications) and there are so many strict laws and regulations regarding the patenting, testing and marketing of drugs in the pharmaceutical industry, it is important that you choose the appropriate translator for your documents. After all, pharmaceutical documents have the potential to change lives.

“We are equipped with 16 years of experience in the fields of translation and localisation, a solid infrastructure of providing comprehensive language services and most importantly a clear vision. We have now proved ourselves as a leading language services provider for both online and offline media and for local and global requirements.” www.ttcltd.com November 2011 | 34


Middle East Hospital

MEH Health and Innovation Awards Winner of the most innovative product for export in the hospital equipment category DDC Dolphin for the Pulpmatic+ Macerator Pulpmatic+ Macerators offer complete hands-free operation by means of a foot plate at the base of the machine and an optical sensor to close and start the machine. The Pulpmatic+ is the only machine with complete hands-free operation making it not only more convenient, but also more hygienic to use than other macerators and reduces the potential for cross contamination.

Visit DDC Dolphin at Medica Hall 16, Stand F04-7

Efficient and Economical Pulpmatics offer greater efficiency, made possible by the unique design features including the Nine-blade maceration disc allowing faster and quieter operation. Not only does this help you cope better with workload peaks, but it translates into significant operating cost savings in terms of staff time and of water and electrical consumption per item processed. Dual Antimicrobial Action In addition to using the latest antimicrobial materials Microbesafe – Silver Nanotechnology in its lid construction, the Pulpmatic+ offers automatic disinfection of the internal maceration chamber. The chamber is rinsed thoroughly, not only with water, but also with DDC disinfectant EcoCleanse+ leaving it clean and smelling fresh. www.ddcdolphin.co.uk

November 2011 | 35


Middle East Hospital

MEH Health and Innovation Awards Winner of the most innovative product for export in the hospital equipment category Sidhil for the Independence Innov8 hospital bed Designed around key principles including ease of use, world class infection control and performance, Independence Innov8 beds are reliable and easy to maintain, incorporating superb ergonomics in terms of both manual handling and user comfort. Solid platform panels with ridges for breathability simplify decontamination and improve infection control, with the bed adjusting to an extremely low level for added safety and convenience in use. Electrically operated functions include auto contouring, giving simultaneous adjustment of backrest and kneebreak. www.sidhil.com

Visit Sidhil at Medica Hall 16, Stand F10-4

Winner of the outstanding contribution to healthcare in the Middle East: surgical instuments Bolton Surgical Bolton Surgical Ltd are manufacturers and suppliers of the finest quality Surgical Instruments and accessories for use within the modern theatre environment. The company has a large customer base of both NHS and private sector hospitals, clinics, and Decontamination Units throughout the UK.

Visit Bolton Surgical at Medica: Hall 16, Stand G18-1

Bolton bring together traditional manufacturing methods with the technology you would expect from a market leader in Surgical Instrument supply, enabling them to provide a totally flexible service tailored to meet the differing and demanding needs of modern theatre and decontamination departments. www.boltons.co.uk November 2011 | 36


Middle East Hospital

MEH Health and Innovation Awards Winner of the European Middle East exporter of the year award Durbin Durbin PLC is a specialist medical supply company that sources and distributes medical equipment, pharmaceuticals and consumable supplies to healthcare professionals in over 180 countries. Established in 1963 in London and with an expected turnover in excess of £40m this year, they have set up their operation to act as a one-stopshop able to deal with healthcare supply needs from local project level to national scale projects. In addition to the export business, they have divisions that handle clinical trial supplies, imported medicines, and family planning supplies. They also handle storage and distribution for a

number of third-parties. Durbin MD Leslie Morgan told MEH, “We deal with a variety of customers in the Middle East, particularly in Saudi Arabia and the UAE. We supply a large range of pharmaceuticals to this region, and are well known for supplying oncology drugs, narcotic analgesics including controlled drugs, and anti-infectives including TB drugs.” He added, “Durbin PLC has over 40 years experience in the UK, European and USA pharmaceutical markets and currently supply over 20,000 branded, generic, medical and consumable products. We have over 20,000 sq feet of warehouse space located close to

and consumable products. We have over 20,000 sq feet of warehouse space located close to Heathrow Airport. This is fitted out to the highest standards including a state-of-the-art evaporative cooling system and walk-in fridges for items requiring storage between 2-8°C. Our logistics team use validated packaging materials and supply routes for temperature sensitive and/or hazardous materials. We also have preferential rates with airlines and all the major freight forwarding companies and our company ethos is ‘saving lives by saving time” www.durbin.co.uk

Winner of the most innovative product for export in the ENT product category Mirage Health Group for the Propulse Proscoop ear wax removal scoop The Propulse ProScoop has been designed in conjunction with a leading ear care specialist to facilitate the manual removal of ear wax before, during and after the ear irrigation process. Supplied individually wrapped and clinically clean, the single use ProScoop helps prevent cross infection. The double ended design combines a scoop for manual ear wax removal at one end, and a serrated edge at the other to allow easy attachment of cotton wool (for mopping out the ear following ear irrigation). Combined with a comfortable and easy to grip plastic handle, the ProScoop ensures that the clinician can confidently remove excess ear wax manually. www.miragehealthgroup.com November 2011 | 37


Middle East Hospital

The Nine Translation Slip-ups to Avoid

#1 Doing it yourself Unless you are a translator, have the relevant skills and experiences, you should not attempt to do this yourself. There is a misconception that anyone who is bilingual will be equally apt to translate a document. However, being bilingual is not a guarantee of written fluency or skill in translation. #2 Relying on machine translation While machine translation has came a long way over the years, resorting to MT for your communication may not be wise. In essence, MT is a quick way for getting the gist or the overall idea of a document. But such tools should not be relied upon for any critical business matters. #3 Not telling your translator what it’s for Before you start off with a translation request, consider the purpose of the translation. Is the material required for a short business email? Is it one that is for publishing on a website, or one where you just want to understand the gist of the information within? #4 Not providing all the details to your translator Consider your translation provider as part of your team and pass them all necessary information before the project starts. Keep them fully informed of any developments during the project.

November 2011 | 38


Middle East Hospital

By Levent Yildizgoren #5 Not agreeing on the quality criteria When quality criteria is not detailed clearly, there is tremendous potential for disappointment. It should be clear right from the start what type of quality assurance is needed. Will a second translator be involved in the editing or proofreading? #6 Not using documents

previously

translated

Your previous translations can be your biggest assets for saving money and ensuring consistency. When it comes to branding, consistency is essential. For a company to hone and polish its image, the last thing that should happen is the message being lost in translation. #7 Choosing the cheapest translator

This article is extracted from a 24 page brochure with the same title. Please email info@ttcltd.com to get a full version. www.ttcltd.com Levent Yildizgoren is the managing director of TTC Language Services Ltd. Please get in touch with him on +44 1245 216930 if you have any questions.

Choosing a translator needs to be done with due diligence. Ask for samples of previously translated documents and a list of satisfied clients. Are they a professional translation provider? Are they a member of any professional organisation? #8 Not planning the translation project It is essential to offer enough time to the translation company. A rushed translation project will often not produce the best results and patching up the subsequent mistakes is certainly something you would want to avoid. #9 Not using plain English in your documents Think international from the start. Avoid references to colour, the human body and anecdotes which are viewed differently by different cultures.

November 2011 | 39


Middle East Hospital

World Health Care Congress Middle East Launched in 2010, the World Health Care Congress Middle East, is the premier conference to feature global health care innovation. It attracts more than 600 senior health care thought leaders from all industry sectors, including hospitals, health systems, employers, government agencies, pharma, biotech and industry suppliers. WHCC Middle East is organized with sovereign partners the Health Authority-Abu Dhabi (HAAD) and the Abu Dhabi Tourism Authority (ADTA). Additional sponsorship is currently provided by The Abu Dhabi Health Services Company (SEHA) and Children’s National Medical Center. More than 600 health care executives representing 25 countries will share their perspectives on best practices for health care delivery; with the Conference to be held at new Abu Dhabi National Exhibition Centre from 11-13 December 2011. Organized Under the Patronage of H.H. General Sheikh Mohammed Bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the United Arab Emirates’ Armed Forces and in collaboration with sovereign partners the Health Authority-Abu Dhabi (HAAD) and the Abu Dhabi Tourism Authority (ADTA), the World Health Care Congress Middle East is the most prestigious health care event, convening global thought leaders and key decision makers from all

Keynote Panel: Global Ministers of Health Discussion - the Global Economic Crisis and its Effect on Health Care * Encourage the case for sustaining investments in health * Build awareness of how the economic crisis affects health spending, health services and health outcomes * Identify actions that can help to mitigate the negative impact of economic downturns and lead to opportunities for reform * Facing the economic downturn through clear integrated human resources and health care facility planning * Highlight the importance of working to promote prevention and a primary health care approach The Honorable Chin Soo Hee, Former Minister of Health and Welfare Ministry of Health and Welfare, South Korea H.E. Prof. Mohamed Jawad Khalifeh, Former Minister of Public Health, Ministry of Public Health; President, Arab Health Ministers Council, Lebanon Anne Milton MP, Minister of State for Public Health, Department of Health, United Kingdom Moderator: Riz Khan, Master of Ceremonies, 2nd WHCC ME; TV Host, Riz Khan Show, Al Jazeera International, United States sectors of health care to promote health care through global best practices. Sunday Morning Leadership Forums will convene ministers of health, department of health officials, health authority and health policy experts to examine and form strategies and

policies to lessen the impact of the economic crisis and provide opportunities for reform to improve health services, health outcomes and reduce health spending. www.worldcongress.com/me

November 2011 | 40


Middle East Hospital

11-13 December 2011, Abu Dhabi What Innovation Means to Health Care * Obstacles to innovations in the developed world * The impact of regulations on innovations * Find out about the World Economic Forum and its partners global project to foster game-changing, innovative delivery solutions * Learn about the four clusters of innovation and key success factors for each cluster * Discover what integrated innovation means for health and biomedical research Prof Abdallah Daar, Professor, Public Health Sciences; Professor, Surgery, University of Toronto, Canada Rt Hon Prof the Lord Ara Darzi of Denham KBE; Paul Hamlyn Chair of Surgery, Imperial College Hospital NHS Trust, United Kingdom Victor Dzau, MD; President and Chief Executive Officer, Duke University Medical Center and Health System, United States Oliver Harrison, MD; Director, Public Health & Policy, Health Authority – Abu Dhabi (HAAD), United Arab Emirates Prof Tan Ser Kiat; Group Chief Executive Officer, Singapore Health Services Pte. Ltd. Singapore

Keynote Panel: Middle East and Northern Africa (MENA) Health Authority Dialogue—Health Care Strategies for the Future and Evidence-Informed Health Policies * Why the development of and what are the changes since of the establishment of health authorities in the UAE * Implementation plans for streamlining guidelines in policies and standards within the Health Authorities and Ministries of Health in Gulf Cooperative Council (GCC) * Views and practices of policy makers about evidence informed policies - the essentials and lessons for developing knowledge translation platforms in MENA countries by discussing progress, examining results and overall challenges * Strengthen health policymaking by identifying priorities, assessing the policy making process, the use of health system evidence in policy and the overall research production * MENA region health challenges and reform priorities * Strategies for improving health systems and attracting medical tourism to the region * Introduction of UAE Hospital Rating System Lalia Al Jassmi, Chief Executive Officer-Health Policy & Strategy Sector, Dubai Health Authority (DHA), United Arab Emirates Zaid Al Siksek, Chief Executive Officer, Health Authority – Abu Dhabi, United Arab Emirates Dr Fadi El Jardali, MPH, PhD; Associate Professor, Health Policy, American University of Beirut, Lebanon Dr Sameh El Saharty, MD, MPH; Sr. Health Policy Specialist, South Asia Region, The World Bank, United States Moderator: Riz Khan TV host George Kurdahi will be master of ceremonies for the event. Best known as host of the Arabic version of Who Wants to Be a Millionaire? (Man sa yarbah al-malyoon), which airs on MBC 1 television, Mr. Kurdahi will preside over the WHCC Middle East’s opening ceremony on 11 December.

November 2011 | 41


Middle East Hospital

MEDICA-COMPAMED 2011 Preview

MEDICA 2011 in D端sseldorf (16 - 19 November) promises an "explosion" of novelties from the medical technology industry. The more than 10,500 new products registered by exhibitors at the MEDICA.de Internet portal are not the only indicators. The MEDICA PREVIEW press event, which took place at the Agaplesion Diaconical Hospital in Hamburg (29 Sept.), already provided a preview of the most significant trends and product

highlights weeks before the opening of the world's biggest medical trade fair. Concerning process innovations in ambulatory and stationary patient care, "networking" is the current catchword with respect to cooperation between the individual players as well as the necessary medical devices. For instance, a concept for optimizing the procedures in operating theatres and endoscopic wards, which has already been implemented at Hamburg's

Diaconical Hospital, was presented at the MEDICA PREVIEW of Olympus (MEDICA exhibitor). Devices from various manufacturers can be easily operated by the attending physician from a central touchscreen. Also integrated are systems for video and image documentation, which also allow the "live" transmission of surgical procedures, including medical imaging from inside the patient's body, to other workstation computers in the hospital. This allows a quick evaluation from

November 2011 | 42


Middle East Hospital

D체sseldorf 16-19 November colleagues within the framework of diagnosis. A novel patient monitoring system from Philips also promises process optimization for doctors and patients alike. It aims to solve the growing need for hospitals to monitor more closely the health of patients even outside the intensive care wards. Nowadays, for economic reasons, intensivecare patients tend to be moved to normal wards sooner and sooner, thus creating demanding challenges for nursing staff for which a solution must be found. This compact, mobile monitoring system relieves hospital staff of the job of carrying out routine measurements every few hours. The system automatically compares the relevant vital data with defined target values and has a system of warning lights to indicate that the patient requires special attention. Meanwhile, Deutsche Telekom has taken up the cause of ensuring healthcare in rural areas by means of telemedicine applications. Amongst other things, it will showcase the "cardiac insufficiency telemedicine workplace" at MEDICA 2011. With a userfriendly device, the patient records data such as ECG, blood pressure and weight. The parameters are sent with Bluetooth via a base station and an Internet connection directly to the patient's electronic medical file at a connected telemedicine centre. There, the data are

monitored and, if necessary, an intervention is initiated. The device provider and technical partner is getemed (also an exhibitor at MEDICA), the medical file was developed by Telekom. Another novelty presented at MEDICA PREVIEW was an

impedance tomography device that makes ventilation processes and their effects on the lung visible, thus allowing improved control options and more precise adjustment of the ventilator (from Dr채ger). What also raised a lot of interest among the journalists was November 2011 | 43


Middle East Hospital

MEDICA-COMPAMED 2011 Preview

an innovative tinnitus therapy device (from ANM) which, based on acoustic neuromodulation, counteracts the pathological hyperactivity of nerve cells in the auditory centre. The aim: To teach the nerve cells to unlearn the tinnitus sound. Increase in bookings at MEDICA and COMPAMED With more than 4,560 exhibitors and 116,000 square meters of booked floor space, MEDICA 2011 is again boasting an increase compared to the previous year. That two thirds of

the exhibitors this year are from outside Germany and that more than 60 countries will be represented at MEDICA 2011 is an indication of the extent of the intense global competition. A strong exchange of goods characterises the market. Over half of the globally manufactured medical devices, products and instruments is destined for export. With more than 600 exhibitors and 11,300 square meters of booked floor space, the parallel trade fair for the supplier market in medical manufacturing, COMPAMED 2011 (16 - 18 Nov.),

is also seeing an increase in bookings (2010: 568; 10,400 m²). MEDICA and COMPAMED will again occupy the entire Dßsseldorf Trade Fair premises with its 19 halls. Their unique combination represents the entire process chain and the complete range of medical products, devices and instruments. The bridge between technical applications, instruments and products and their uses with respect to the diagnosis and therapy of specific diseases is realized at MEDICA through the November 2011 | 44


Middle East Hospital

D端sseldorf 16-19 November combination of the trade fair and its integrated theme parks and forums such as MEDICA MEDIA FORUM (telemedicine / medical IT, Hall 15), MEDICA TECH FORUM (Innovations in Medical Technology in Practical Application, Hall 11), MEDICA VISION (innovation forum of the research institutes, Hall 3) and MEDICA PHYSIO FORUM (presentation of physiotherapy applications, Hall 4). A new topic in the programme themes at MEDICA this year is the MEDICA WOUND CARE FORUM in Hall 6. In the midst of all the action on every event day it will be providing information on current trends and approaches with respect to qualified care of chronic wounds. Permanent fixtures at MEDICA are the MEDICA Congress, Germany's biggest interdisciplinary training forum with several thousand participants, and the German Hospital Conference , the leading communication platform for decision-makers at German hospitals. This year for the first time the EUROPEAN HOSPITAL CONFERENCE will take place under the auspices of German Hospital Conference. This event is directed towards top decision-makers at European hospitals. Its agenda is drafted by the European Hospital and Healthcare Federation HOPE, the European Association of Hospital Managers EAHM and the European Association of Senior Hospital Physicians AEMH. November 2011 | 45


Middle East Hospital

ABHI UK Pavilion The Association of British Healthcare Industries is once again organising the UK Pavilion at MEDICA, housing oround 100 of the UK’s most innovative medtech SMEs. This year ABHI International has launched a new website ABHI UK Pavilion [www.abhiukpavilion.org] to promote UK medical technology manufacturers to the world. This online resource will support the work of ABHI International in helping it’s exhibitors gain access to foreign markets for their innovative healthcare products. Paul Benton, Director of ABHI Exhibitions, said, “Through this portal UK companies will enjoy a vastly enhanced online visibility to potential buyers, distributors, clinicians, and anyone else with an interest in the UK medical technology industry from across the globe. Journalists can visit the site and find a substantial amount of ready-to-use information on UK companies and products, and visitors can also follow us on Facebook and Twitter (@ABHIexhibitions) to keep updated.” About ABHI ABHI is a Government “Accredited Trade Organisation” (ATO). As an ATO ABHI organises the official UK pavilions at key medical technology exhibitions around the world. ABHI works closely with UK Trade and Investment and Department of Health International to ensure

maximum benefit for UK pavilion exhibitors. This work includes supporting trade missions, and organising events to support and educate UK exporters. Participation in the UK Pavilion provides companies with exposure, opportunities, support and assistance that they would not receive attending independently. Eligible companies may also apply for government grants to support exhibition costs.

ABHI streamlines exhibition preparation ensuring that companies save time and effort. Infotainment Arm Exhibiting in the UK Pavilion for the first time at MEDICA are Colebrook Bosson Saunders (Hall 16, Stand G25-2), leading designers and manufacturers of ergonomic support products. Colebrook Bosson Saunders will launch three new products at the exhibition, including their patient November 2011 | 46


Middle East Hospital

Düsseldorf 16-19 November infotainment arm: CBS-Hi1. CBSHi1 has been developed exclusively for the healthcare market to meet the computing and multimedia needs of hospital patients and staff. CBS-Hi1 enables a screen (increasingly used for patients’ healthcare, entertainment, communication and information needs) to be safely mounted to a wall and easily adjusted. Amongst all the flat screen supports on the market CBS-Hi1 has the strength and adaptability to carry the largest spectrum of weights, ranging from 3.5 to 9KG. The product’s flexibility helps to future proof installations – as the technology is updated the support can continue to be used. The inherent strength of the product means that it is equally suitable for touch-screen devices, enabling patients to communicate with staff. Diagnostic devices Also exhibiting for the first time are Max Medical (Hall 16 Stand G20-8). Their product range includes the highest quality diagnostic devices, first aid equipment and medical disposables. To meet their clients increasing demand Max Medical are continuously developing and expanding their product ranges. New products on display at Medica include first aid kits, blood glucose monitoring devices, and blood pressure monitors. They will also be showcasing their medical disposable ranges, including wound dressings, thermometers,

The CBS-Hi1 Infotainment Arm will be display in Hall 16 Stand G25-

Max Medical’s product range will be on display in Hall 16 Stand G20-8

syringes, bandages, surgical gowns, and medical tape. Commercial Director, Victoria Sikopoulis, said: “I am very pleased Max Medical will be exhibiting at Medica for the first time this year. I am looking forward to meeting with visitors and exhibitors alike, and building strong, successful, relationships with businesses from around the world.We will have on show our latest diagnostic devices, which

combine a minimal compact design with accuracy and ease of use to deliver maximum efficiency. All our products have been awarded CE certificates.” On display for the first time at Medica will be the MiniproSelf Monitoring Blood Glucose System. This is a small, unique, friendly design, and offers one of the most minimal blood test samples on the market. www.abhiukpavilion.org November 2011 | 47


Middle East Hospital

Advances in Implant Medicine Advances in the field of implant medicine are one of the top subjects at MEDICA 2011 There is hardly a medical field that does not use an implant of one kind or another, from dental to ENT medicine to orthopaedics and, of course, accident surgery. Easier said than done, the challenge in bone surgery is: To make an implant strong enough to stabilize fractures, for instance, but which will dissolve over time, eliminating the need for its surgical removal. Magnesium implants do just that. Implants such as those successfully used for decades in orthopaedic and accident surgery should, in general, meet multiple criteria, for instance: • must have a surface that will readily grow into one with the bone • must be biocompatible and not release any toxic substances • must be bioresorbable, being replaced with the body's own tissue • must be able to withstand sterilisation without losing any positive properties • must be porous enough that cells and blood vessels can grow into it • and must be mechanically stable so that patients can use their limbs as soon as possible after surgery. Still a great challenge "Despite all efforts, there is still no implant or bone replacement material that completely fulfils all these criteria," says Dr. Sascha Heinemann of the Max Bergmann Center of Biomaterials at the

Technical University of Dresden. Decisive for implant quality is not only the correct choice of material but also an optimal surface structure. For instance, the biocompatibility is clearly determined by the roughness of the surface. This also applies for dental implants, whose roughness in the nanometre range (billionths of a meter) determines its protein binding capacity and consequently how fast it will grow into the jaw bone. In light of this, Alicona Imaging GmbH (exhibitor at COMPAMED) has developed

an innovative 3-D surface measuring technology that is excellently suited for the surface characterization of implants. "Cost-efficient measuring means analysing all the relevant parameters with a single system, and that's exactly what our InfiniteFocus does," explains Dr. Stefan Scherer, CEO of Alicona Imaging GmbH. It combines the options of a roughness and a shape-measuring device, thus providing all the functionalities of an optical profilometer and a

November 2011 | 48


Middle East Hospital

MEDICA-COMPAMED 2011 Preview polyorthoester (POE). Pins made of PDS (Ethipin) and PGA (Biofix), for instance, have been used clinically since 1985. However, both materials degrade very quickly and therefore rapidly lose their strength. The degradation times were increased significantly by using the polymer PLA. Cardiovascular implants – a market worth billions The market for cardiovascular implants, worth around 15 billion dollars worldwide, is considered extremely attractive. In addition, the importance of coating technologies for catheters and stents is increasing because, amongst other things, they make innovative and individualized medical therapies possible.

micro-coordinate measuring machine. Even with complex shapes and different material properties, the user obtains a resolution of up to 10 nanometres and that even over large vertical and lateral scanning areas. For complete measurement of the shape, it has an optional rotation unit that turns the sample 360°. "We know of no comparable optical measuring system that provides such substantiated information on roughness, even over wide measuring ranges," confirms Dr. Frank Rupp, head of

the "Interface analysis of medical materials" work team at the Tübingen Polyclinic. Implants that dissolve in the body within a defined period of time represent a particular challenge. For a long time now, implants such as these have been developed and used to fix small bone fragments in place, for instance. The self-dissolving polymers used for this include: polylactide (PLA), polyglycolid (PGA), polydioxanon (PDS), poly hydroxy butyric acid (PHB) and

"Coatings increase functionality, lifetime and cost efficiency, improve the guidance and positioning of parts, and they facilitate handling and reduce the patient's risk of injury," explains Prof. Hans-Wilhelm Engels, head of the Innovation Community Council and head of research in the area of paints, adhesives and specialties at Bayer MaterialScience (COMPAMED exhibitor). The coating materials that can be used include hydrophile polymers and polymers with good gliding properties such as polyvinyl pyrrolidone (PVP), polyethylene glycol / poly ethylene oxide (PEG/PEO), polyvinyl alcohol (PVA) as well as hyaluronic acid. As these compounds are often November 2011 | 49


Middle East Hospital

MEDICA-COMPAMED 2011 Preview water soluble they must be stabilized through cross-linking. Just recently Bayer introduced Baymedix CD 500, a new coating into which the agents can be integrated. These stable coatings allow the programmable release of a number of different agents, from small molecules all the way to protein therapeutics. The biocompatibility of these systems was confirmed in in-vitro and invivo tests. "We are also already working on optimal systems for biodegradable stents," says Engels. Maximum stability through "bone welding" A procedure in bone surgery has been creating a furor for several years now as the idea originated in the watchmaking industry and was developed further in the furniture industry. The procedure in question is the WoodWelding technology of the Swiss company WoodWelding. In this procedure, also known as bone welding, synthetic implants (lactic acid polymers) are fixed in the bone by means of ultrasound. The first company licensed to use the method was Germany's KLSMartin SA (exhibitor at MEDICA). The first application of the patented technology has been approved in the USA and Europe for face and skull surgery since the end of 2005. The technology can also be used in spinal column surgery as well as in dental and sports medicine. With the SonicWeld Rx procedure of KLS Martin Group, the pin is made to

vibrate by precisely defined ultrasound frequencies. When it is placed on a pre-drilled hole, the pin liquefies and penetrates hollow spaces that conventional screws cannot reach. The threedimensional anchoring ensures maximum stability. Bone welding works in cancellous and cortical bone. The connection is stable within seconds.

magnesium alloy products are available to date. However, the positive developments raise hopes that the special properties of the light metal would benefit the clinical field, says Hanover implant researcher Professor Frank Witte, whose research won the Ministry of Education and Research prize for innovation in medical technology in 2009.

Nevertheless, the bone pin selfdegrades completely. A second surgical intervention is not necessary. And: The implantation time is significantly shorter than for conventional resorbable implants. Moreover, there is no risk of implant fractures.

Currently, the research in metalbased bone replacement materials is primarily focused on magnesium-based materials, which are considered promising.

Resorbable metal implants: Magnesium and iron make it possible So-called magnesium-based implants are almost the "latest rage" in bioresorbable implants. What's so special? Over time they dissolve through corrosion, but they are metal implants and, being different from other bioresorbable implants made of polymers, are very stable and, therefore, suitable for supporting functions. As implants made of Mg alloys have similar elasticity modules as bone tissue, there is no bone resorption at the implantation location. Attempts were made to use magnesium as implant material as early as the 19th century, for instance for blood vessel ligatures. However, no commercial magnesium-based or

However: To date they do not possess the necessary mechanical properties and degrade too quickly. Researchers at LMU Munich, the Fraunhofer Institute for Manufacturing Technology (exhibitor at COMPAMED) and InnoTERE GmbH Dresden have, therefore, developed a degradable ironbased alloy which in toxicological studies proved to be welltolerated. However, it will be several years before such iron-based implants will be commercially available. What Sirris, the Belgian centre of competence for the technology industry, has planned is also still a thing of the future: resorbable implants from a 3-D printer in conjunction with the quick-change artists amongst the cells: stem cells. It appears that the old adage "nature is the best engineer" still holds true.

November 2011 | 50


Middle East Hospital magazine November 2011 issue  

Middle East Hospital magazine November 2011 issue

Advertisement
Read more
Read more
Similar to
Popular now
Just for you